Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2798745 in Chronic Cough
NCT03372603Phase 2Terminated
- Sponsor
- GSK
- Start
- Apr 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK2798745 in chronic cough (2 arms), sponsored by GSK. Primary endpoint: Total Cough Counts During Day Time Hours Following 7-days of Dosing. Started Apr 2018; status: terminated.
02
Drugs
GSK2798745
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT03372603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03372603.